SEC Form 4 · accession 0001144204-16-075152
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur Przybyl
Officer — President and CEO · Director
Period of report
Jan 8, 2016
Accepted (ET)
Jan 11, 2016 · 4:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 8, 2016 | M | 16,446 | $6.36 | A | 160,321 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock | $6.36 | Jan 8, 2016 | M | 16,446 | D | Jul 12, 2014 | Jul 11, 2023 | Common Stock | 16,446 | 64,387 | D |